Enakshi Singh - 11 Mar 2022 Form 4 Insider Report for Zymergen Inc.

Role
Chief Financial Officer
Signature
/s/ Mina Kim, attorney-in-fact
Issuer symbol
N/A
Transactions as of
11 Mar 2022
Net transactions value
$0
Form type
4
Filing time
15 Mar 2022, 20:29:54 UTC
Previous filing
30 Dec 2021
Next filing
15 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZY Common Stock Award $0 +250,000 +110% $0.000000 477,000 11 Mar 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units (RSUs) that vest 1/24 on each monthly anniversary of the first day of the calendar month immediately following the Grant Date, March 11, 2022, subject to the grantee's continuous service through each such vesting date.
F2 Includes 77,000 Restricted Stock Units (RSUs) that vest 1/3 on November 1, 2022 and the remaining 2/3 on November 1, 2023, subject to the Reporting Person's continued service to the Company through the vesting date.